COVID 19: Evaluate of Liver and Renal Function Tests in Iraqi Patients

Authors

  • Abdullah Ali Mohammed1 , Mahmood Nazar Mustafa2 , Sura A. Abdulsattar3 , Ahmed Salam Al-zaidi4

DOI:

https://doi.org/10.37506/mlu.v21i1.2268

Keywords:

COVID 19; liver enzyme; urea; creatinine; AST, ALT.

Abstract

The clinical features of COVID-19 are varied, ranging from asymptomatic state to acute respiratory distress
syndrome and multi organ dysfunction. We aim to evaluate renal and liver functions of patients with COVID
19. Laboratory results were obtained from 107 patients with laboratory-confirmed COVID-19 who were
admitted to the only Al-Furat General Hospital in Baghdad, Iraq from March 3 to June 9, 2020 and followed
up until recovery. Normal levels of renal functions were presented. Meanwhile elevated levels of alanine
aminotransferase (ALT) was observed in 10% and of aspartate aminotransferase (AST) was observed in
40% of patients with COVID 19,yet on comparison of the results at entering with at recovery it was observed
significant differences (p<0.01) of all patients. From these findings we conclude that the virus might be
responsible for systemic inflammation.

Author Biography

  • Abdullah Ali Mohammed1 , Mahmood Nazar Mustafa2 , Sura A. Abdulsattar3 , Ahmed Salam Al-zaidi4

    1Assistant Lecturer (M.Sc.) Department of Chemistry and Biochemistry, 2Assistant Lecturer (M.Sc.) Department of
    Pathology and Forensic Medicine, University of Fallujah, College of Medicine, Iraq, 3
    Prof. Dr. (PHD) Department
    of Chemistry and Biochemistry, Mustansiriyah University, College of Medicine, Iraq, 4
    (M.Sc.) Department of
    Medical Analysis, Al-Furat General Hospital, Iraq

Downloads

Published

2021-01-09

Issue

Vol. 21 No. 1 (2021): Medico-Legal Update

Section

Articles

How to Cite

COVID 19: Evaluate of Liver and Renal Function Tests in Iraqi Patients. (2021). Medico Legal Update, 21(1), 7-10. https://doi.org/10.37506/mlu.v21i1.2268